Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0476
-0.0058 (-10.82%)
At close: Mar 26, 2026

PVCT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.250.310.080.020.68
Cash & Short-Term Investments
0.250.310.080.020.68
Cash Growth
-18.26%301.49%254.44%-96.84%602.43%
Accounts Receivable
--00-
Other Receivables
----0.01
Receivables
--000.01
Prepaid Expenses
0.320.490.340.470.33
Restricted Cash
-0.180.951.412.42
Total Current Assets
0.570.981.361.93.44
Property, Plant & Equipment
0.130.030.080.140.07
Total Assets
0.71.011.452.043.51
Accounts Payable
0.721.111.682.091.29
Accrued Expenses
3.312.353.392.482.02
Short-Term Debt
0.220.210.280.240.24
Current Portion of Long-Term Debt
2.612.952.681.831.46
Current Portion of Leases
0.050.030.050.040.05
Current Unearned Revenue
-0.340.951.512.5
Other Current Liabilities
----0.15
Total Current Liabilities
6.96.989.028.197.7
Long-Term Debt
0.02----
Long-Term Leases
0.08-0.030.07-
Total Liabilities
76.989.048.277.7
Common Stock
0.420.420.420.420.42
Additional Paid-In Capital
256.18251.09244.71242.95241.44
Retained Earnings
-262.85-257.42-252.69-249.59-246.03
Comprehensive Income & Other
-0.06-0.06-0.06-0.04-0.03
Total Common Equity
-6.31-5.97-7.62-6.25-4.21
Minority Interest
-0-0.01---
Shareholders' Equity
-6.3-5.97-7.59-6.23-4.19
Total Liabilities & Equity
0.71.011.452.043.51
Total Debt
2.983.183.032.181.74
Net Cash (Debt)
-2.73-2.88-2.95-2.16-1.06
Net Cash Per Share
-0.01-0.01-0.01-0.01-0.00
Filing Date Shares Outstanding
420.28420.28419.52419.5419.45
Total Common Shares Outstanding
420.28420.28419.52419.5419.45
Working Capital
-6.33-6-7.65-6.29-4.26
Book Value Per Share
-0.02-0.01-0.02-0.01-0.01
Tangible Book Value
-6.31-5.97-7.62-6.25-4.21
Tangible Book Value Per Share
-0.02-0.01-0.02-0.01-0.01
Machinery
-0.120.120.120.12
Source: S&P Global Market Intelligence. Standard template. Financial Sources.